Finally, 1 H NMR provided evidence regarding the molecular interactions between FFA, coformers and polymers at atomic level and gave insight into the mechanism underlying the supersaturated solution and subsequent permeation behaviour of the cocrystals.
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INTRODUCTION
Over the last decade, pharmaceutical cocrystals have been studied extensively as potential tools to optimise the drug product performance, in particular for compounds with limited aqueous solubility/dissolution rates. [1] [2] [3] However, the supersaturated solution generated by dissolution of the highly soluble cocrystals was thermodynamically unstable and the parent drug had a tendency of rapid precipitation. [4] [5] [6] It was shown that the parent drug tended to precipitate directly onto the surface of the dissolving cocrystals during dissolution, acting as a coating layer to diminish the dissolution and solubility of the cocrystals. 4, 5 In sight of this, inclusion of effective crystallisation inhibitors in the formulations have been explored to maintain the supersaturated conditions of API (active pharmaceutical ingredient). 4, [6] [7] [8] [9] [10] [11] On one occasion, an excess use of coformer or micellar solubilisation decreased the solubility of cocrystals, leading to a lower degree of supersaturation and subsequent prevention of drug precipitation. 7, 8 Maintaining supersaturated drug concentration was also achieved by introducing stabilizing agents in the formulation, that the equilibrium solubility of the drug was not enhanced but the nucleation and/or crystal growth of the drug were inhibited by the intermolecular interactions between the drug molecules and the stabilizing agents. Although polymeric crystallisation inhibitors have been widely used in amorphous solid dispersion formulations to stabilize the amorphous state of the drug substance and to maintain its supersaturated status in solution, 12, 13 such studies have rarely been carried out in cocrystal based formulations. 4, 9, 10, [14] [15] [16] The selection of a polymeric excipient in a cocrystal formulation seemed to be much more complicated than those used in the solid dispersion system because the inhibitory ability of the polymers could be undermined significantly by the competitions between the drug, the coformer and the polymer in terms of hydrogen bondings. 9 Furthermore, a dissolved polymer could alter the dissolution of the cocrystals and subsequently affect its inhibitory ability on the precipitation of the parent drug. 4 For orally administered solid dosage forms of a drug compound, the elevation of drug concentration in the gastrointestinal (GI) tract did not always improve the absorption as the drug molecules have to permeate across the GI membrane. It was reported that, despite of an increased solubility due to the presence of co-solvent, micelle, cyclodextrin, hydrotropy and emulsifier, a reduced fraction of free drug for membrane permeation by drug encapsulation could eventually lead to very poor drug absorption. [17] [18] [19] [20] [21] [22] [23] [24] [25] Therefore, the balance between the solubility and the permeability had to be optimised to achieve the maximal overall absorption of a poorly water soluble drug. The drug permeability of an amorphous solid dispersion formulation was highly polymer dependent. 20, [26] [27] [28] [29] A few evidence showed that the cocrystals alone could alter both the solubility and the permeability of the APIs. [30] [31] [32] Though it was not clear that, in a cocrystal based formulation, how the permeability of the parent drug was affected by additional polymeric excipients, some speculated that the interplay of the solubility and permeability was the determining factor for a successful formulation.
Our previous investigations found that inclusion of the polymers of polyvinylpyrrolidone (PVP) and copolymer of vinyl pyrrolidone/vinyl acetate (PVP-VA) altered the dissolution of cocrystals of flufenamic acid-nicotinamide (FFA-NIC) and flufenamic acid-theophylline (FFA-TP) and maintained the supersaturation of FFA in solution. 33 In this work we pioneered a systematic examination of key processes occurred during cocrystal dissolution of FFA-NIC and FFA-TP in the absence and presence of PVP or PVP-VA at different concentrations to reveal the kinetics of drug supersaturation and permeation. The molecular structures of FFA cocrystals and the monomer units of the polymers were shown in Table 1 and a detailed description could be found from previous work. 4, 9, 34, 35 Simultaneous evaluations of the dissolution of FFA cocrystals in the absence and presence of PVP or PVP-VA as well as the permeation of FFA through a dialysis membrane were achieved using a dissolution/permeation (D/P) system (Fig. 1) . The dialysis membrane modelled the intestinal epithelium. The D/P system represented a simplified permeation model for quantitative analysis because of the negligible effect of polymer on the membrane. 28, 36, 37 And it had been proved to be a useful tool for examining the absorption of oral drugs after administration. [36] [37] [38] [39] [40] [41] In the D/P system, the powdered drug substances were applied to the donor compartment, which was filled with dissolution media in the absence or presence of the polymer at various concentrations, under nonsink conditions to evaluate the ability of the polymer to maintain the supersaturated drug solution. Meanwhile, the amount of FFA molecules permeated into the acceptor compartment, which was filled with the dissolution media, was monitored. The temperature of the whole D/P system was maintained at 37°C using a circulating water bath. The molecular interactions of the FFA, coformers and polymers were analysed by one-dimensional proton nuclear magnetic resonance µg/mL, 500 µg/mL, 1000 µg/mL, 2000 µg/mL, 4000 µg/mL, 8000 µg/mL, 12000 µg/mL and 16000 µg/mL. Appropriate amount of the powdered FFA crystals was then added to these solutions for the apparent equilibrium solubility test. The FFA crystals were slightly grounded by a mortar and pestle and passed through a 60 mesh sieve so that the particle size of the crystals was no more than 250 µm. The test was carried out for 24 h at a temperature of 37 ± 0.5°C with constant mixing at 150 r.p.m. cocrystals. An appropriate amount of the FFA crystals was then added to these solutions for the apparent equilibrium solubility test.
The Dissolution and Permeation
Measurements. The D/P system was used to evaluate the dissolution and permeation of cocrystals. It consisted of a donor and an acceptor compartment, which was separated by a regenerated cellulose membrane with a Molecular Weight Cut-Off (MWCO) of 6-8 KDa (Spectrum Labs Inc. Rancho Dominguez, CA 90220, USA) ( Fig. 1 ). Either the donor or acceptor compartment has a capacity of 10 mL. The orifice diameter of the compartment was 0.9 cm, The dissolution performance parameter (DPP) 52 was used to evaluate the dissolution of the FFA cocrystals, as detailed previously, 4 and the dissolution of FFA crystals was used as the reference. The difference of the DPP of the FFA cocrystals measured in the absence and presence of PVP or PVP-VA would give indication of the effect of the polymers on dissolution and on the maintenance of drug supersaturation.
The flux of a drug through the membrane, which was defined as the amount of drug crossing a unit area perpendicular to its flow direction per unit time t, was calculated using the following equation:
where ‫)ݐ(ܬ‬ was the flux of a drug; ‫ܥ‬ ௧ భ was the drug concentration (µg/mL) at ‫ݐ‬ ଵ ; ‫ܥ‬ ௧ మ was the drug concentration (µg/mL) at ‫ݐ‬ ଶ ; V was the solution volume and A is the area of exposed membrane. All the samples were prepared in deuterated chloroform (CDCl 3 ) using the standard 5 mm NMR tubes and the spectra of tetramethysilane (TMS) was used as an internal standard. Detailed measurements were shown in Table S1 To mimic a cocrystal system, the FFA and its coformers were included in the solution at 1:1 molar ratio. Three sets of concentrations were prepared for the simulated cocystal system: 215 µg/mL NIC/ 320 µg/mL TP and 500 µg/mL FFA; 430 µg/mL NIC/640 µg/mL TP and 1000 µg/mL FFA; 2150 µg/mL NIC/3200 µg/mL TP and 5000 µg/mL FFA. For investigation of the effect of polymer on the simulated cocrystal system, PVP or PVP-VA was included in the solution at a concentration of 200 µg/mL or 5000 µg/mL, respectively. Table 2 . 
RESULTS
Effects of Polymer and/or Coformer on the Equilibrium Solubility of
FFA. The effects of polymer and/or coformer on the equilibrium solubility of FFA were shown in Fig. 2 . The equilibrium solubility of FFA at 37°C measured in PBS was 9.0 ± 0.7 µg/mL. PVP had a moderate effect, which the solubility of FFA was slightly increased with the PVP concentration of 1000 µg/mL and it reached the maximum of 14.9 ± 1.0 µg/mL at the PVP concentration of 2000 µg/mL. In contrast, the effect of PVP-VA could be seen at the concentration of 1000 µg/mL and it became more prominent with the increase of the concentration. In fact, the solubility of FFA reached 17.2 ± 1.6 µg/mL at a PVP-VA concentration of 4000 µg/mL and 37.6 ± 0.5 µg/mL at a PVP-VA concentration of 16000 µg/mL.
Whereas the presence of NIC seemed to have no effect, the presence of TP at a concentration of 71.1 µg/mL increased the equilibrium solubility of FFA to 10.24 ± 0.71 µg/mL. Neither NIC nor TP altered the equilibrium solubility of FFA in the solution containing PVP. In contrast, the presence of NIC or TP further enhanced the solubility FFA observed in solutions containing PVP-VA.
Effect of Polymers on the Dissolution and Permeation of FFA Cocrystals.
The dialysis membrane acted as a selective barrier for the substances to pass through based on their sizes. The MWCO of the dialysis membrane used in the study was 6-8
KDa and it would thus allow the transfer of FFA, which has a molecular weight 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 With an increased concentration, the self-association of FFA could also occur through the inter carboxylic acid hydrogen bondings, which was demonstrated by a downfield chemical shift of H h from 8.049 ppm at 500 µg/mL to 8.061 ppm at 1000 µg/mL, and to 8.082 ppm at 5000 µg/mL. This could be due to proton deshielding by the hydrogen bonds, which the lengthening of the O-H bond reduced the valence electro density around the proton of H h . The intermolecular association between the dimer of FFAs did not affect the molecular conformation in solution and the intramolecular N-H j ···O=C was not disrupted. 54 Therefore, at an increased concentration of FFA, the peaks of H j displayed an upfield shift from 9.463 ppm at 500 µg/mL to 9.443 ppm at 1000 µg/mL, and to 9.410 ppm at 5000 µg/mL. The self-association of NIC in solution occurred through inter-amide hydrogen bonding but not the stacking of the pyridine rings. 58 Therefore, with an increased NIC concentration, the downfield shifts of H a and H b were observed. This was in contrast to H c , whose spectra was almost 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Fig. 9 (a) shown by the constant spectra of H j .
Effect of PVP or PVP-VA on the Dissolution and
1 H NMR Analysis of Ternary Components.
1 H NMR spectra of the mixed samples of FFA, NIC/TP and PVP/PVP-VA were shown in Fig. 10 . When the concentration of PVP was set to 200 µg/mL, the characteristic peaks of the H h and H j in FFA moved upfield, suggesting that, as a result of the interactions between the FFA and the PVP, the hydrogen bonds formed between the FFA and NIC were disrupted [ Fig. 10 (a) ]. In contrast, PVP-VA at 200 µg/mL had no effect on the spectra of the H h and H j in FFA, indicating that the interaction between the FFA and NIC played a dominant role over the interaction between the FFA and PVP-VA [ Fig. 10 (b) ].
Increasing PVP or PVP-VA to a concentration of 5000 µg/mL rendered the peaks of H j and H h moved to opposite directions [ Fig. 10 (a) and Fig. 10-(b) ]. This might reflect the dominant effect caused by the hydrophobic interaction between the FFA 
DISCUSSION
This research demonstrated that the supersaturated drug concentration generated by the cocrystal dissolution could be maintained through inclusion of a polymeric excipient in the formulation, for example, the supersaturated concentration of FFA generated by dissolution of FFA-NIC or FFA-TP was maintained by PVP or PVP-VA[ Fig. 4 (a) ]. 4, 9, 10 On the other hand, in the presence of PVP or PVP-VA, the DPP detected for FFA-NIC or FFA-TP was proportional to the concentration of the polymers and it was much higher than that detected without PVP or PVP-VA [ Fig. 4 (a)]. However, as shown in the D/P system, an elevated concentration of FFA in the donor compartment was not accompanied by an increased flux rate of FFA to the acceptor compartment [Fig, 4 (b) ]. This erratic drug permeation could lead to poor drug bioavailability, which was crucially related to the amount of drug molecules that could pass through the GI membrane. Therefore, it was important to explore the interplay of the solubility and permeability in the cocrystal based formulation, that enhanced solubility/dissolution might have positive, negative or no effect on the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 subsequent permeability. [18] [19] [20] 29 The mechanism of how a polymer affected the dissolution of the cocrystals had been investigated, and it seemed that the polymer could interact with the surface of the cocrystal to alter both the dissolution and precipitation. 4 As a further investigation, this research revealed the interactions between the drug substance (FFA), the coformer (NIC or TP) and the polymer (PVP or PVP-VA) in solution and how these interactions maintain the supersaturated drug concentration and the subsequent permeation of the drug substance.
Both PVP and PVP-VA are water soluble polymers. However, due to their structural difference (Table 1) Fig. 4(a) ]. In contrary, the effect of PVP-VA on the flux rate of FFA-NIC or FFA-TP could be greater or smaller than PVP, which was seemingly concentration dependent (Fig. 4) . In fact, for FFA-NIC and FFA-TP, while the FFA flux rates and DPPs measured were in proportion to the concentration of PVP, the FFA flux rates measured were in contrast to the DPPs in the presence of PVP-VA (Fig. 4) . Therefore, it was essential to take into account both the flux rate and DPP when evaluating a cocrystal based formulation.
Based on the results in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 flux rate was determined by the degree of supersaturation (ratio of dissolved amount of unchanged API to its thermodynamic solubility), which was the driving force for transporting the drug substance across the membrane. 29 PVP might inhibit the nucleation of FFA to maintain its supersaturated concentration [ Fig. 5 (a) ] 9 and to increase the flux rate of FFA across the regenerated cellulose membrane [ Fig.5 (b) ]. 29 Due to the bulk precipitation dissolution mechanism, the higher supersaturation concentration of FFA generated by FFA-TP led to a higher flux rate in comparison to FFA-NIC. 4 When the concentration of PVP was above 4000 µg/mL, the attraction between FFA and PVP changed into hydrophobic interaction due to the confined spaces between the FFA and PVP molecules. This was confirmed by the upfield chemical
shifts of H h in FFA [ Fig. 8 (a) ]. It must be stressed that, at such a concentration, micellization of PVP did not occur due to its rigorous backbone structure and, therefore, PVP had no significant effect on the equilibrium solubility of FFA (Fig. 2) .
Consequently, the mobility of FFA in solution was seen to reduce with the increased concentration of PVP, as illustrated by the broaden peak of the H j in FFA [ Fig. 8 (a) ].
The reduced flux rate of FFA at a PVP concentration of 16000 µg/mL [ Fig. 4 (b) ]
was the result of a combined effects of the reduced dissolution of the cocrystals [ Fig.   5 (a) ] and the reduced solute activity coefficient. 37 Although the interaction between FFA and PVP was disturbed by the interaction between PVP and the coformers ( Fig.   9 and Fig. 10 ), the role of PVP as a stabilizing agent did not change, as demonstrated by the minor change of FFA solubility with or without the presence of the coformers (Fig. 2) . As a consequence, the flux rate of FFA solely depended on the DPP of the cocrystals, which the maximal flux rate of FFA was observed for FFA-TP in the presence of 4000 µg/mL of PVP. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 As seen in Fig.2 , PVP-VA had a transitional role in the cocrystal formulation, depending on its concentrations. At a concentration of up to 1000 µg/mL and the absence of NIC or TP, PVP-VA acted as a stabilizing agent as it had no effect on the equilibrium solubility of FFA (Fig. 2) . The downfield shifts of the H h in FFA indicated the formation of hydrogen bond between the FFA and the PVP-VA [ Fig. 8 (a)]. Compared to PVP, PVP-VA was more hydrophobic and flexible, leading to micellization at a higher concentration. 61 This research set the critical micelle concentration (CMC) of PVP-VA at 4000 µg/mL. Therefore, at a concentration over the CMC, PVP-VA significantly increased the solubility of FFA. The 1 H NMR spectra of FFA showed the upfield shifts of the H h at PVP-VA concentration of 5000 µg/mL [ Fig. 8 (a) ], from which the conclusion could be drawn that the encapsulation of FFA took place in PVP-VA micelles. In other words, the role of PVP-VA changed to a solubilisation agent in the formulation.
In the presence of NIC or TP, PVP-VA demonstrated a significant solubilisation capacity (Fig. 2) . It was likely that the association of PVP-VA with a coformer , as shown in Fig. 8 (b) and Fig. 8(c) , provided an expanded region of the inner core for drug solubilization. 62 The CMC of PVP-VA reduced significantly around 200 µg/mL, at which point the equilibrium solubility of FFA started to increase (Fig. 2) . Taken together, it seemed that PVP-VA behaved as a solubilisation agent in the cocrystal formulations regardless of its concentrations.
Corresponding to the increased equilibrium solubility of FFA, the DPPs of the FFA cocrystals were proportional to the concentration of PVP-VA [ Fig. 4 (a) ]. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 concentrations by increasing the equilibrium solubility rather than increasing the chemical potential (degree of supersaturation), as shown by the reduced flux rate of FFA across the membrane [ Fig. 4 (b) ]. This was in consistent with the findings from previous studies.
18 -20, 29 Overall, the permeation of a FFA cocrystal could be affected by a series of factors, such as the types of polymers, the concentrations of the polymers and coformers. In particular, the interactions between the polymer and the coformer might play roles in improving the absorption of the drug substance.
CONCLUSION
The 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 at molecular level was the key to optimise the solubility and permeability to maximize the performance of cocrystal based oral drug products.
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